key: cord-0805934-3xqymf0e authors: Mu, Tong; Yi, Zumu; Wang, Minjin; Wang, Junren; Zhang, Chongwei; Chen, Hong; Bai, Mingxuan; Jiang, Lingyu; Zhang, Yuwei title: Expression of eosinophil in peripheral blood of patients with COVID‐19 and its clinical significance date: 2020-10-29 journal: J Clin Lab Anal DOI: 10.1002/jcla.23620 sha: 3f8d7702861f08668205e191941ea3c57761566a doc_id: 805934 cord_uid: 3xqymf0e AIMS: To investigate the eosinophil cell (EC) expression in peripheral blood of patients infected with severe acute respiratory syndrome coronavirus 2(SARS‐CoV‐2) and its clinical significance of diagnosis and prognosis. METHODS: 95 patients, whose nucleic acid test of SARS‐CoV‐2 was positive to make a definite diagnosis of COVID‐19, were selected as the study group. They were admitted at the Chengdu Public Health Clinical Medical Center from January 21 to March 2, 2020. Another 95 healthy subjects and 95 non‐infectious fever patients during the same period were selected as the control group. The BC‐6900 blood cell analyzer was used to continuously observe and detect ECs in 95 patients with COVID‐19 and the control group. The differences in expression levels of ECs in peripheral blood were analyzed. RESULTS: ECs were significantly decreased in 95 (75.8%) COVID‐19 patients (P < .01). The absolute EC count IQR was 0.01 × 10⁹/L (0 × 10⁹/L − 0.04 × 10⁹/L), and the EC percentage IQR was 0.3% (0.1% − 0.8%). As the patients’ condition improved, the ECs returned to normal, but for those without improvement, ECs continued to decline. CONCLUSIONS: ECs decreased remarkably in patients with COVID‐19, and gradually returned to normal after the improvement of the patients’ condition, while EC continued to decrease in patients without improvement. It is suggested that ECs have certain clinical significance in the diagnosis and prognosis of COVID‐19, and may be a useful index in the early warning of acute infectious diseases. Since December 2019, multiple cases of patients infected by SARS-CoV-2 have been discovered in Wuhan, China. It has transmitted in an extremely short period to more than 100 countries, resulted in the infection of more than 100,000 people by March 07, 2020. Current research indicated that SARS-CoV-2 showed a resemblance of more than 85% to batSL-CoVZC45. 1 to the diagnosis and treatment program, clinical classification is divided into mild, ordinary, and severe, and critical severe COVID-19 patients meet one of the following conditions: ①shortness of breath, RR > 30 counts per minute; ② resting state, oxygen saturation <93%; ③partial pressure of artery (PaO2)/fraction of inspiration (FiO2) <300 mmHg; and ④pulmonary imaging showed that the lesions progress more than 50% within 24-48 hours. Critical COVID-19 patients meet one of the following conditions: ①Respiratory failure occured and requires mechanical ventilation. ②Shock occurred; ICU monitoring and treatment were required for combined organ failure. Another 95 healthy subjects and 95 non-infectious fever patients during the same period were non-randomly selected as the control groups. There was no significant difference in comparison of baseline characteristics data such as age and gender between the three groups. Chengdu Public Health Clinical Medical Center is one of the designated hospitals for inpatient treatment of COVID-19 patients. Demographic data, clinical characteristics (including medical history, exposure history, comorbidities, surgery history, signs and symptoms), chest computed tomography (CT) or X-ray results, and laboratory test results of each patient were obtained from the electronic medical record system. Analysis was performed by three independent researchers. Our research was approved by the Research Ethics Committee, West China Hospital, Sichuan University. The BC-6900 blood cell analyzer was applied to continuously ob- Continuous variable descriptions use median and interquartile range (IQR) values (when n ≤ 3, the median, maximum, and minimum values are used for description). In order to compare the continuous variables of different patient groups, Mann-Whitney test was applied. The data were collected and organized with Microsoft Excel 2016, and the data analysis is completed by IBM SPSS statistics 21 software. Significance was defined at the 5% level (P < .05). According to the dynamic observation of ECs in 95 patients with COVID-19 (3 dead cases included), 92 patients' EC count recovered with the improvement of their condition (P < .01). The absolute value of EC in 3 cases of death continued to be low, sometimes the test value was zero, which was not improved compared with that at the time of admission (P < .01). (Tables 2 and 3 ). According to the laboratory examination results of patients diagnosed with COVID-19 (Table 4 ), the number of lymphocytes in most patients decreased, the percentage of lymphocytes decreased, the concentration of CRP increased, while the patients with abnormal serum procalcitonin concentration and CD4/CD8 ratio accounted for less in all patients. According to the classification criteria, we included mild and ordinary patients in non-severe group, while severe and critical patients in severe group. There were significant differences in lymphocyte number, lymphocyte percentage, CRP, EC number, and EC percentage between the non-severe (mild and ordinary type) and severe (severe and critical type) groups. The decrease of lymphocytes and ECs was more obvious in severe groups. The concentration of CRP was higher. This study included 95 community-infected COVID-19 patients. Analysis of EC of the 95 patients with COVID-19 showed that 75.8% of them had significantly lower absolute and relative EC values than normal at the time of first admission. It was suggested that the decreased EC might be an indicator for SARS-CoV-2 infection in suspected patients. At present, there are many studies on inflammatory indexes such as lymphocytes in COVID-19, and few reports on ECs only point out the phenomenon of eosinopenia in patients. 2 The main difficulty in the diagnosis of fever of unknown origin is the lack of effective and rapid diagnostic methods. The unknown epidemiological history and non-specific laboratory results often make the clinical diagnosis of the disease in trouble. 3 However, the current study on many inflammatory indicators has not found specific indicators that are helpful to distinguish from common infection. In this study, compared with the non-infectious fever patients, the absolute value of EC in patients with COVID-19 was lower, and the difference was significant (P < .01), which may be helpful for the diagnosis and differential diagnosis of COVID-19. According to the current report, the patients with COVID-19 have the phenomenon of decrease in the total number of leukocytes and lymphocyte count in the early stage of the disease, 2 while for the atypical patients without lymphocyte reduction and imaging changes, eosinopenia may become an important diagnostic clue. ECs are a variety of white blood cells and one of the immune system components, which can produce a variety of pro-inflammatory mediators and immunoregulatory molecules. During the Th2 immune response, ECs from the bone marrow and blood are recruited to the site of inflammation to play a role. 4 Clinically, eosinopenia is common in typhoid fever, paratyphoid fever, severe tissue damage after surgery, and after application of adrenocortical hormone or adrenal hormone. We found the phenomenon of eosinopenia in COVID-19 patients, which may be of reference value for improving the differential diagnosis of eosinopenia-related diseases. ECs gradually returned to normal as their condition improved, while ECs continued to decrease in severe or fatal cases. In 2 of the 3 fatal cases, the absolute count of the last EC measurement before the death of patients decreased to 0. The decrease of ECs might TA B L E 1 Level of EC in COVID-19 group, non-infectious fever group, and normal control group Previous studies have shown that the mechanism of eosinophilia was mainly induced by mast cells through the production of chemokines, which were induced by pro-inflammatory mediators (such as IL-1 and TNF-α) and eosinophil-directed cytokines (such as IL-4 and IL-5). 4 Studies on the infection mechanism of MERS-CoV have also shown that the characteristic inflammatory cells of infected lung tissues are ECs and neutrophils, respectively. 12 Therefore, the decrease of ECs in peripheral blood of patients with COVID-19 may also be related to this mechanism. The study on the mechanism of eosinophilic granulocytopenia has also led us to further explore the immune damage of corona- To the best of our knowledge, the named authors have no conflict of interest, financial or otherwise. Tong Mu, Zumu Yi, and Minjin Wang conceived the study design, wrote the original draft, and collected the data. Junren Wang conceptualized the study and provided the resources. Chongwei Zhang analyzed and interpreted the data. Hong Chen collected the data. Mingxuan Bai analyzed and interpreted the data. Lingyu Jiang revised the study. Yuwei Zhang conceptualized the study and wrote, reviewed, and edited the article. None declared. None declared. The datasets of the present study are available from the corresponding author on reasonable request. National Health Commission of the people's Republic of China. Diagnosis and treatment of novel coronavirus pneumonia (trial version sixth) Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan Fever of unknown origin: focused diagnostic approach based on clinical clues from the history, physical examination, and laboratory tests Eosinophilic lung diseases Cytokine imbalance in infants receiving extracorporeal membrane oxygenation for respiratory failure A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms Detection and monitoring of SARS coronavirus in the plasma and peripheral blood lymphocytes of patients with severe acute respiratory syndrome The effect of SARS coronavirus on blood system: its clinical findings and the pathophysiologic hypothesis Clinical and Laboratory findings of MERS-CoV infection Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus Prior immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV Comparative pathology of rhesus macaque and common marmoset animal models with Middle East respiratory syndrome coronavirus